Table 4.
Population clinical and laboratory data.
| N = 56 (100%) | |
| Mean (SD) | |
| BW z-score | 1.10 (0.89) |
| Height z-score | 0.49 (0.97) |
| DBP (mmHg) | 67.21 (7.96) |
| TC (mg/dL) | 165.54 (24.55) |
| LDL-C (mg/dL) | 95.91 (18.99) |
| Apo B (mg/dL) | 71.36 (13.80) |
| AI-1 (LDL-C/HDL-C) | 1.77 (0.59) |
| AI-2 (LDL-C/ApoB) | 1.34 (0.13) |
| Median (IQR) | |
| BMI z-score | 1.34 (0.36–1.74) |
| SBP (mmHg) | 118.00 (107.25–124.50) |
| HDL-C(mg/dL) | 54.00 (46.00–65.00) |
| Non-HDL-C (mg/dL) | 113.50 (89.00–121.75) |
| TGs (mg/dL) | 63.00 (47.25–83.75) |
| Apo A1 (mg/dL) | 142.00 (130.50–155.75) |
| Al-3 (TG/HDL-C) | 1.04 (0.76–1.84) |
| hsCRP (n = 45) | 0.54 (0.26–2.01) |
BW: body weight; DBP: diastolic blood pressure; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; Apo B: apolipoprotein B; AI: atherogenic index; BMI; body mass index; WC: waist circumference; SBP: systolic blood pressure; HDL-C: high-density lipoprotein cholesterol; Non-HDL-C: non-high-density lipoprotein cholesterol; TGs: triglycerides; Apo A1: apolipoprotein A1; hsCRP: high-sensitivity C-reactive protein.